1. Home
  2. CMPS vs CRML Comparison

CMPS vs CRML Comparison

Compare CMPS & CRML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMPS
  • CRML
  • Stock Information
  • Founded
  • CMPS 2020
  • CRML N/A
  • Country
  • CMPS United Kingdom
  • CRML United States
  • Employees
  • CMPS N/A
  • CRML N/A
  • Industry
  • CMPS Biotechnology: Pharmaceutical Preparations
  • CRML
  • Sector
  • CMPS Health Care
  • CRML
  • Exchange
  • CMPS Nasdaq
  • CRML NYSE
  • Market Cap
  • CMPS 364.9M
  • CRML 147.9M
  • IPO Year
  • CMPS 2020
  • CRML N/A
  • Fundamental
  • Price
  • CMPS $4.80
  • CRML $2.18
  • Analyst Decision
  • CMPS Strong Buy
  • CRML
  • Analyst Count
  • CMPS 7
  • CRML 0
  • Target Price
  • CMPS $18.83
  • CRML N/A
  • AVG Volume (30 Days)
  • CMPS 1.6M
  • CRML 5.2M
  • Earning Date
  • CMPS 07-31-2025
  • CRML 02-01-2025
  • Dividend Yield
  • CMPS N/A
  • CRML N/A
  • EPS Growth
  • CMPS N/A
  • CRML N/A
  • EPS
  • CMPS N/A
  • CRML N/A
  • Revenue
  • CMPS N/A
  • CRML $476,979.00
  • Revenue This Year
  • CMPS N/A
  • CRML N/A
  • Revenue Next Year
  • CMPS N/A
  • CRML N/A
  • P/E Ratio
  • CMPS N/A
  • CRML N/A
  • Revenue Growth
  • CMPS N/A
  • CRML 326.80
  • 52 Week Low
  • CMPS $2.49
  • CRML $1.23
  • 52 Week High
  • CMPS $8.54
  • CRML $12.00
  • Technical
  • Relative Strength Index (RSI)
  • CMPS 60.99
  • CRML 57.91
  • Support Level
  • CMPS $4.33
  • CRML $1.39
  • Resistance Level
  • CMPS $5.14
  • CRML $3.58
  • Average True Range (ATR)
  • CMPS 0.38
  • CRML 0.33
  • MACD
  • CMPS -0.01
  • CRML 0.14
  • Stochastic Oscillator
  • CMPS 70.83
  • CRML 38.05

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

About CRML CRITICAL METALS CORPORATION

Critical Metals Corp is engaged in lithium exploration in Austria. It is focused on the development of its wholly-owned Wolfsberg Lithium Project (the Wolfsberg Project) located in Carinthia, Austria.

Share on Social Networks: